Acadia Pharmaceuticals (ACAD)Frazier Life Sciences Management, L.P. opened a new position $13.1M

614K

Shares reported

0.39%

Disclosed portfolio weight

$13.1M

Reported value

Holdings as of

Sep 30, 2025

Filed

Nov 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 15, 2025InsiderCFO sold ~$83K of ACAD shares in the open market
2. Oct 28, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 28, 2025, Daniel B. Soland notified the Board of Directors (the “Board”) of Acadia Pharmaceuticals Inc. (the “Company”) of his resignation from the Board and from his positions as a member and Chair of the Nominating and Corporate Governance Committee of the Board, effective as of October 30, 2025.”
3. Nov 5, 2025Company filing · Form 8-K · ResultsReported its results

What came next

1. Jan 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
2. Feb 25, 2026Company filing · Form 8-K · ResultsReported its results
3. Mar 3, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 3, 2026, the board of directors (the “Board”) of Acadia Pharmaceuticals Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Jonathan M. Poole to the Board to fill a vacancy and as a member of the Audit Committee of the Board, effective immediately.”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Acadia Pharmaceuticals

For Acadia Pharmaceuticals, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACAD page.

How this filing works

• SEC Form 13F

Other disclosures at Acadia Pharmaceuticals

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 13, 2026
• SEC Form 13F-HRFeb 13, 2026
• SEC Form 13F-HRNov 14, 2025

Everything OQRO holds on this company is on its ACAD page.